Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections.
Osterhaus
A D
AD
Laboratory of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
Weijer
K
K
Siebelink
K H
KH
Rimmelzwaan
G F
GF
Bosch
M L
ML
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D002415:Cats; D016181:Feline Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D007116:Immunization, Passive / Q000662:veterinary; D016089:Immunodeficiency Virus, Feline / Q000276:immunology*; D005256:Leukemia Virus, Feline / Q000276:immunology*; D016582:Leukemia, Feline / Q000517:prevention & control*; D015682:Retroviridae Proteins, Oncogenic; D014611:Vaccination / Q000662:veterinary*; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
D000888:Antibodies, Anti-Idiotypic; D015682:Retroviridae Proteins, Oncogenic; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; C045569:feline leukemia virus vaccine